Myllylä Minna, Anttalainen Ulla, Saaresranta Tarja, Laitinen Tarja
Department of Pulmonary Diseases, Division of Medicine, Turku University Hospital and University of Turku, Hämeentie 11, FI-20520, Turku, Finland.
Sleep Research Centre, Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland.
Sleep Breath. 2020 Sep;24(3):1089-1095. doi: 10.1007/s11325-020-02023-2. Epub 2020 Feb 14.
Obstructive sleep apnea (OSA) has been associated with a 2- to 7-fold risk of motor vehicle accidents (MVAs). Continuous positive airway pressure (CPAP) treatment may reduce MVA risk. We further explored this issue in long-term CPAP users and untreated controls.
We used both before-after and case-control study designs. The observational cohort consisted of CPAP-treated and untreated patients matched for gender, age, and apnea-hypopnea index. All MVAs reported to the police were identified.
A total of 2060 patients (75.8% male, mean age 56.0 ± 10.5 years) were included. The CPAP-treated patients (N = 1030) were screened for MVAs for a median of 9.0 years before and after treatment. The median CPAP usage was 6.4 h/day. The control patients (N = 1030) were screened for MVAs for a median of 6.5 years after discontinuation of CPAP. No significant differences were observed between the incidences of MVAs per 1000 person years before treatment (3.2), after treatment (3.9), or in controls (2.6). Compared with controls, patients who had MVA after treatment had a higher body mass index (BMI), but did not differ in terms of other baseline characteristics, sleep study data, or accident conditions. In the majority of these patients, daytime sleepiness was reduced, whereas BMI tended to increase during treatment.
The MVA incidence did not change after CPAP treatment. Among the patients who had MVA, BMI was the only baseline characteristic that differed between the groups and tended to further increase after CPAP treatment. Differences in sleep study data or accident conditions were not observed.
阻塞性睡眠呼吸暂停(OSA)与机动车事故(MVA)风险增加2至7倍相关。持续气道正压通气(CPAP)治疗可能降低MVA风险。我们在长期使用CPAP的患者和未治疗的对照组中进一步探讨了这个问题。
我们采用了前后对照和病例对照研究设计。观察队列包括根据性别、年龄和呼吸暂停低通气指数匹配的接受CPAP治疗和未治疗的患者。确定所有向警方报告的MVA。
共纳入2060例患者(75.8%为男性,平均年龄56.0±10.5岁)。接受CPAP治疗的患者(N = 1030)在治疗前后接受MVA筛查的中位时间为9.0年。CPAP的中位使用时间为每天6.4小时。对照组患者(N = 1030)在停用CPAP后接受MVA筛查的中位时间为6.5年。治疗前每1000人年的MVA发生率(3.2)、治疗后(3.9)或对照组(2.6)之间未观察到显著差异。与对照组相比,治疗后发生MVA的患者体重指数(BMI)较高,但在其他基线特征睡眠研究数据或事故情况方面无差异。在这些患者中的大多数,白天嗜睡有所减轻,而治疗期间BMI往往增加。
CPAP治疗后MVA发生率没有变化。在发生MVA的患者中,BMI是两组之间唯一不同的基线特征,并且在CPAP治疗后有进一步增加的趋势。未观察到睡眠研究数据或事故情况的差异。